Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Auto Added by WPeMatico
Oracle stock wavered following a report that the tech giant landed a $7 billion cloud deal with Tencent. The post Oracle Lands Major Cloud Deal With Tencent appeared first on Investor’s Business Daily.
Micron Technology delivered a sizable beat-and-raise earnings report, but it didn’t do much for Micron stock. The post Micron Faces Tough Crowd After Fiscal Q4 Beat-And-Raise Report appeared first on Investor’s Business Daily.
Wall Street cheered Alphabet’s release of a new artificial-intelligence model, called Gemini 4 Argon, after delays. Google stock climbed. The post Will Google Turn The Tables In AI Race? Wall Street Reacts To Gemini 4. appeared first on Investor’s Business…
Moderna stock rallied by triple digits when positive news rolled in for its cancer vaccine. But is mRNA ready to return to the limelight? The post Is A Cancer Vaccine Coming? Moderna, Merck Boosted By The Buzz appeared first on…
Wall Street cheered Alphabet’s release of a new artificial-intelligence model, called Gemini 4 Argon, after delays. Google stock climbed. The post Google’s Gemini 4 Takes Aim At Wall Street’s AI Doubts — And Rivals’ Pricing appeared first on Investor’s Business…
Accenture stock rose sharply Thursday after the global technology services firm reported fiscal fourth-quarter earnings and revenue that topped estimates while its fiscal 2027 outlook came in above expectations as… Read More The post Accenture Surges On Fiscal Q4 Beat,…
Alphabet released its most powerful, artificial intelligence model called Gemini 4 Argon. Google stock climbed on the news. The post Google Stock Rises On Gemini 4 Argon Release After New AI Model Delays appeared first on Investor’s Business Daily.
Micron Technology beat Wall Street’s sky-high targets for its fiscal fourth quarter and with its outlook. Micron stock rose modestly on the news. The post Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above Views appeared first on Investor’s Business…
A district judge ruled Wednesday that Liquidia infringed on United Therapeutics’ patents with its drug, Yutrepia. The stocks diverged. The post United Just Pulled The Ultimate Bull Move, As Its Chief Rival Collapsed appeared first on Investor’s Business Daily.
Eli Lilly already beat its next-generation weight-loss drug, retatrutide, and it hasn’t even hit the market. The post Move Aside Retatrutide, Eli Lilly Just Beat Its Next-Gen Obesity Drug appeared first on Investor’s Business Daily.
